(Stroke. 2002;33:67.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurology (M.D., J.H., N.P.) and Neuroradiology (M.H., T.A.K.), Klinikum Grosshadern, Ludwig Maximilians University, München, and Institut für klinische Neuropathologie Zentralkrankenhaus Bremen Ost, Bremen (M.B.), Germany.
Correspondence to Dr Martin Dichgans, Department of Neurology, Klinikum Großhadern, Marchioninistraße 15, D-81377 München, Germany. E-mail mdichgans{at}nefo.med.uni-muenchen.de
| Abstract |
|---|
|
|
|---|
Methods Gradient-echo, T2/PD-weighted dual-echo, and T1-weighted MRI scans of the brain were obtained from 16 consecutive CADASIL subjects and 16 age-matched control subjects. T2-lesion volume measurements were made with a semiautomated segmentation technique based on local thresholding. Postmortem examinations were performed on the brains of 7 additional CADASIL subjects.
Results Focal areas of signal loss on gradient-echo images suggesting past MBs were found in 11 CADASIL individuals (69%) and no control subjects (P<0.001). The average number of MBs was 5.9±7.3 (range, 0 to 22) in individual CADASIL patients. MBs were associated with age (r=0.71, P=0.002) and total lesion volume (r=0.75, P=0.001). However, after correction for age, the correlation with lesion volume was no longer significant. MBs were located simultaneously in various parts of the brain with a preference for cortical-subcortical regions (38%), white matter (20%), thalamus (13%), and brainstem (14%). Eighty-two percent of the MBs were located outside areas appearing hyperintense on T2-weighted images. Postmortem examination revealed focal accumulations of hemosiderin-containing macrophages in 6 of the 7 brains (86%). They were always found outside ischemic lesions.
Conclusions This study shows a high frequency and multiplicity of MBs in individuals with CADASIL. Our results suggest that MBs and ischemic lesions are largely independent manifestations of the underlying angiopathy. The pattern of MBs shows a significant overlap with that reported in other types of small-vessel disease.
Key Words: angiopathy CADASIL echo-planar imaging intracerebral hemorrhage
| Introduction |
|---|
|
|
|---|
MRIs show lacunar infarcts and less well demarcated subcortical T2 hyperintensities that may show different degrees of hypointensity on T1-weighted scans.79 These alterations are caused by a unique type of nonarteriosclerotic, amyloid-negative angiopathy involving small arteries and capillaries primarily in the brain but also in other organs.10 Ultrastructural examination reveals characteristic granular osmiophilic material within the vascular basal lamina, which is often seen in close association with vascular smooth muscle cells. Vascular smooth muscle cells have been shown to degenerate and eventually disappear.11 Together, these changes contribute to progressive disintegration of the vascular wall.
Recent MRI studies of patients with other types of small-vessel disease (SVD) such as cerebral amyloid angiopathy and hypertensive SVD have called attention to a high frequency of petechial hemorrhages (microbleeds [MBs]) in these conditions.1217 MBs have further been observed in asymptomatic elderly individuals.18 They were found to be associated with age, hypertension, and extensive white matter changes,18,19 which are risk factors or indicators of SVD. MBs have thus been connected to structural alterations of small blood vessels. From these findings, we hypothesized that the angiopathy in CADASIL may similarly predispose to MBs.
At the site of an ICH, hemosiderin remains stored in macrophages. T2*-weighted gradient-echo (GE) pulse sequences enhance the magnetic susceptibility (and resultant signal dropout) caused by the deposition of chronic blood products in tissues, thus increasing the sensitivity for hemorrhages.20 Because hemosiderin remains stored at the site of a hemorrhage for many years, GE MRI is suited to assess the overall pattern of past hemorrhages.13,16
In the present study, we obtained GE and dual-echo MRI scans (1) to determine the frequency, extent, and pattern of MBs in CADASIL and (2) to analyze the relationship between MBs and T2-hyperintense lesions. Postmortem examinations were performed on the brains of 7 additional CADASIL patients to investigate the histopathology of brain tissue affected by MBs.
| Patients and Methods |
|---|
|
|
|---|
1 of the following manifestations: migraine with aura (n=8 patients), transient ischemic attacks and/or stroke (n=13), dementia (n=1), or depression (n=3). In all cases, the diagnosis had been confirmed either by skin biopsy (n=10)2123 or by demonstration of a Notch3 mutation (n=14): R90C (n=4), C93F, R110C, R133C, R169C (n=2), R182C (n=2), C194F, or delD239-D253 (n=2).24,25 Control subjects consisted of 16 age-matched healthy subjects (5 men, 11 women; mean age, 49.7±9.4 years; range, 32 to 63 years). Informed consent was obtained from all subjects before study initiation. None of the 32 subjects had taken oral anticoagulants in the past. Moderately elevated blood pressure levels (systolic pressure, between 140 and 160 mm Hg) were found in 2 CADASIL patients and 1 control subject. There was no history of head trauma, intracranial tumors, coagulopathy, or ICH in any of the subjects.
MRI Study
MRI scans were obtained from all subjects with the same 1.5-T system (Magnetom Vision, Siemens). Twenty-four contiguous axial 5-mm-thick slices (no interslice gap) were obtained with the following pulse sequences: (1) T2/PD-weighted dual-echo fast spin echo (repetition time [TR], 3300 ms; echo time [TE], 16/98 ms; field of view [FOV], 250 mm; matrix, 192x256) and (2) T1-weighted spin echo (TR, 768 ms; TE, 14 ms; FOV, 250 mm; matrix 192x256). Twenty-two axial contiguous 5-mm-thick slices (interslice gap, 1.5 mm) were obtained with a T2*-weighted GE sequence (TR, 1000 ms; TE, 22 ms; flip angle, 40°; FOV, 210 mm; matrix, 224x256). T2*-weighted GE images were also obtained in the coronal plane (23 contiguous 4-mm-thick slices without interslice gap). The axial slices were positioned on a plane that joined the most inferoanterior and inferoposterior parts of the corpus callosum.
Images were jointly analyzed by 3 raters (T.A.Y., M.H., M.D.). Focal areas of prominent signal loss on T2*-weighted images were analyzed. MBs were defined as homogenous rounded lesions with a diameter >2 mm.14,15,18 Areas of symmetric hypointensity of the globus pallidus, likely to represent calcifications or nonhemorrhagic iron deposition, were disregarded.18,26 Vascular flow void artifacts were excluded by tracing areas of local signal loss on adjacent slices. The number of MBs was separately assessed for each of the following locations: cortical (ie, strictly limited to the cortex), cortical-subcortical, white matter, basal ganglia (caudate nucleus, putamen, globus pallidus), thalamus, brainstem (midbrain, pons, medulla oblongata), and cerebellum (cortical-subcortical, white matter, deep nuclei). MBs were further classified according to their spatial relationship to T2-hyperintense lesions as follows: within lesions (ie, surrounded by a rim of T2-hyperintense signal), adjacent to lesions (<3 mm apart), or at distance from lesions (
3 mm) appearing hyperintense on T2/PD-weighted images. Any abnormalities present on the MRI scans were identified consensually by the 3 observers. Lesion volume measurements were performed with a semiautomated segmentation technique based on local thresholding.27
Autopsy Study
Postmortem examinations were done on the brains of 7 additional CADASIL cases (5 men, 2 women) who had come to autopsy between 1986 and 1998. None of them had previously been investigated by GE MRI, thus precluding a correlation study between neuroimaging and postmortem findings. In 6 of them, mutational screening of the Notch3 gene revealed a deleterious mutation (R110C, R117F, R133C, C174Y, C185R). Age at death ranged from 28 to 64 years (mean, 52.3±13.2 years). The postmortem delay was 5 to 48 hours. Brains were fixed in an unbuffered 7% formaldehyde solution for
2 weeks and were cut into 1-cm coronal (6 cases) or horizontal (1 case) sections. The brainstem was cut into horizontal sections. Large hemispheric tissue blocks were taken from the frontal lobe at the plane of the tip of the anterior horn, precentral region with temporal lobe at the plane of the striatum, postcentral region at the plane of the geniculate bodies, and occipital lobe adjacent to the posterior horn. Additional tissue was taken from optic nerves and chiasma, geniculate bodies, cortex, midbrain, pons, medulla, and cerebellum.
The tissue was embedded in paraffin wax and cut into 10-µm sections for histology. Each tissue block was processed for the following staining methods (1 section each): hematoxylin and eosin, cresyl violet, Klüver-Barrera myelin stain, Bodian silver impregnation for axons, van Giesons stain for elastic fibers, Perls reaction for hemosiderin, periodic acid-Schiff reaction, and congo red (for amyloid).
MBs were defined as focal accumulations of hemosiderin-containing macrophages17 visible on Perls reaction stains. Hemosiderin deposits not contained within macrophages and limited to the basal ganglia, likely to represent nonhemorrhagic iron deposition, were disregarded.28
Statistical Analysis
Statistical evaluation was performed with the Statistical Analysis System version 8.01 for Windows (SAS Institute). Differences between CADASIL individuals and control subjects were investigated with Fishers exact test. Correlations between neuroimaging variables and age were calculated with the Spearman rank correlation coefficient. To correct for multiple testing, a value of P
0.01 was considered significant.
| Results |
|---|
|
|
|---|
GE T2*-weighted MRIs revealed MBs in 11 CADASIL individuals (69%) and no control subjects (P<0.001) (Figure 1). The total number of MBs in CADASIL individuals was 94 (mean, 5.9±7.3; men, 6.7±8.1; women, 5.4±7.1). The number of MBs detected in CADASIL individuals correlated with age (r=0.71, P=0.002) and volume of lesions (r=0.75, P=0.001). However, after correction for age, the correlation with lesion volume was no longer significant (partial correlation coefficient=0.48, P=0.07).
|
The number of MBs found in individual CADASIL patients ranged from 0 to 22. In most cases, MBs were noticed simultaneously in various parts of the brain (Figure 1). The distribution of MBs was as follows (in descending order): cortical-subcortical, 36 (38%); white matter, 19 (20%); brainstem, 13 (14%: pons, 9; medulla, 3; midbrain, 1); thalamus, 12 (13%); basal ganglia, 7 (8%); cerebellum, 4 (4%; white matter, 3; cortical-subcortical, 1; deep nuclei, 0); and cortical, 3 (3%). The size of the MBs ranged from 2 to 10 mm, with most (90%, n=85) ranging from 2 to 5 mm.
Seventy-seven of the MBs (82%) were located outside areas appearing hyperintense on T2/PD-weighted images (Figure 1). More specifically, 47 MBs (50%) were located at a distance from (
3 mm) and 30 MBs (32%) were located adjacent to (<3 mm) such areas. Seventeen MBs (18%) were found within areas appearing hyperintense on dual-echo scans.
Autopsy Study
All 7 autopsy cases showed lacunar infarcts and diffuse white matter changes, with the latter consisting of various degrees of demyelination, axonal loss, gliosis, and enlargement of the extracellular spaces. In all cases, electron microscopy revealed characteristic granular osmiophilic material within the basal lamina of small blood vessels.10,29
Focal accumulations of hemosiderin-containing macrophages were found in all but 1 of the 7 brains (86%) examined. The single patient without past hemorrhages was younger (age, 28 years) than those with such findings (mean age, 56.5±8.2 years; range, 48 to 65 years). A total of 7 past hemorrhages were found in the following locations: white matter (n=2), basal ganglia (n=1), pons (n=2), and optic nerve (n=2). Their size ranged from 0.2 to 1.0 mm, and they were seen only at the microscopic level. In all cases, siderophages were found in the vicinity of small blood vessels (diameter, 100 to 300 µm), which showed degenerative changes in their wall but were surrounded by intact-appearing tissue with no evidence of ischemic damage (Figure 2). In none of the cases was there evidence of vascular amyloid by congo red staining. In addition, there was no evidence of vascular malformations or parenchymal calcifications.
|
| Discussion |
|---|
|
|
|---|
Our findings confirm and extend previous studies indicating a strong association between MBs and SVD.14,16,17 Vascular abnormalities in CADASIL involve virtually all layers of the vascular wall.10,11,29,30 Moreover, some authors have described Charcot-Bouchard aneurysms.31 It is conceivable that these changes may affect the vulnerability of blood vessels in CADASIL.
MBs were found to be scattered throughout the brain without a clear predilection for one specific structure. This agrees with the generalized nature of the underlying angiopathy. Most MBs were found to be located outside T2 hypersignals. Similarly, on histopathological analysis, hemosiderin-containing macrophages were found within largely intact brain tissue. These findings suggest that most petechial hemorrhages occur independently from ischemic lesions in CADASIL. Our observations are in some contrast with findings in sporadic SVD. Tanaka et al14 found MBs to be commonly surrounded by T2-hyperintense areas. On histopathological analysis, they found foci of old hemorrhages to be regularly associated with gliosis and ischemic lesions.14 However, in another study, the association between hemosiderin deposits and tissue necrosis was less consistent.17 In our CADASIL population, only a small proportion of MBs were found to be located within areas appearing hyperintense on T2-weighted scans. Given the large volume of T2 hypersignals, the observed colocalization could be coincidental. Alternatively, it could indicate some direct relationship between ischemic lesions and petechial hemorrhages in a subset of MBs. Experimental and clinical studies have shown secondary alterations in vascular permeability and vessel wall integrity after the occlusion of large arteries.3234 However, whether such secondary changes occur in SVD is still unknown.
In this study, we found a significant correlation between age and number of MBs. Similarly, there was a strong correlation between age and volume of lesions appearing hyperintense on dual-echo scans, as expected from previous studies.35,36 In contrast, there was no significant correlation between the number of MBs and volume of lesions when age is introduced as a covariate. These findings are in keeping with the chronic nature of the underlying angiopathy and its proposed role in causing 2 largely independent complications: ischemic lesions and petechial hemorrhages.
The clinical implications of MBs in CADASIL are unknown. From large patient series, there is no evidence of an increased frequency of hemorrhagic stroke.3,4 However, there have been 2 reports on normotensive CADASIL patients who died after an ICH.5,6 None of them had been investigated for the presence of MBs. Quite relevantly, 1 of the patients had been treated with oral anticoagulants. Thus, it is premature to conclude that there is an increased frequency of ICH or a predictive potential of MBs in CADASIL. However, in view of the known risk for anticoagulant-related ICH in patients with extensive white matter lesions,37 particular caution must be advised in giving oral anticoagulants to CADASIL patients.
It has been suggested that particular angiopathies are associated with specific patterns of MBs. Thus, for example, there is evidence of a high frequency and preferential occurrence of cortico-subcortical MBs in cerebral amyloid angiopathy.12 The results of the present study and those of others15,16,18 indicate a considerable overlap between the distribution of MBs seen in different conditions. Consequently, the diagnostic importance of particular MB patterns remains questionable, whereas the presence of MBs appears to be a valuable indicator for SVD.
| Acknowledgments |
|---|
Received June 20, 2001; revision received October 5, 2001; accepted October 8, 2001.
| References |
|---|
|
|
|---|
2. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL: a hereditary adult-onset condition causing stroke and dementia. Nature. 1996; 383: 707710.[CrossRef][Medline] [Order article via Infotrieve]
3. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998; 44: 731739.[CrossRef][Medline] [Order article via Infotrieve]
4. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, et al. Clinical spectrum of CADASIL: a study of 7 families: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995; 346: 934939.[CrossRef][Medline] [Order article via Infotrieve]
5. Sourander P, Walinder J. Hereditary multi-infarct dementia: morphological and clinical studies of a new disease. Acta Neuropathol (Berl). 1977; 39: 247254.[CrossRef][Medline] [Order article via Infotrieve]
6.
Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke. 1993; 24: 122125.
7.
Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG. Patterns of MRI lesions in CADASIL. Neurology. 1998; 51: 452457.
8.
Yousry TA, Seelos K, Mayer M, Bruning R, Uttner I, Dichgans M, Mammi S, Straube A, Mai N, Filippi M. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol. 1999; 20: 91100.
9.
Auer DP, Putz B, Gossl C, Elbel GK, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001; 218: 443451.
10. Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997; 56: 947964.[Medline] [Order article via Infotrieve]
11. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl). 1995; 89: 500512.[Medline] [Order article via Infotrieve]
12.
Greenberg SM, Finklestein SP, Schaefer PW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology. 1996; 46: 17511754.
13.
Greenberg SM, ODonnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology. 1999; 53: 11351138.
14.
Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke. 1999; 30: 16371642.
15.
Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2000; 31: 26652669.
16. Roob G, Fazekas F. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol. 2000; 13: 6973.[CrossRef][Medline] [Order article via Infotrieve]
17.
Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999; 20: 637642.
18.
Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999; 52: 991994.
19. Kwa VI, Franke CL, Verbeeten B Jr, Stam J. Silent intracerebral microhemorrhages in patients with ischemic stroke: Amsterdam Vascular Medicine Group. Ann Neurol. 1998; 44: 372377.[CrossRef][Medline] [Order article via Infotrieve]
20.
Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T: comparison with spin-echo imaging and clinical applications. Radiology. 1988; 168: 803807.
21. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994; 25: 22912292.[Medline] [Order article via Infotrieve]
22. Ebke M, Dichgans M, Bergmann M, Voelter HU, Rieger P, Gasser T, Schwendemann G. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997; 95: 351357.[Medline] [Order article via Infotrieve]
23. Mayer M, Straube A, Bruening R, Uttner I, Pongratz D, Gasser T, Dichgans M, Muller-Hocker J. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol. 1999; 246: 526532.[CrossRef][Medline] [Order article via Infotrieve]
24. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997; 350: 15111515.[CrossRef][Medline] [Order article via Infotrieve]
25. Dichgans M, Ludwig H, Müller-Höcker J, Messerschmidt A, Gasser T. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet. 2000; 8: 280285.[CrossRef][Medline] [Order article via Infotrieve]
26. Forstl H, Krumm B, Eden S, Kohlmeyer K. Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation. J Neurol. 1992; 239: 3638.[CrossRef][Medline] [Order article via Infotrieve]
27.
Filippi M, Iannucci G, Tortorella C, Minicucci L, Horsfield MA, Colombo B, Sormani MP, Comi G. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 1999; 52: 588594.
28. Disorders of mineral metabolism.In: Cervos-Navaro J, Urich H, eds. Metabolic and Degenerative Diseases of the Central Nervous System. San Diego, Calif: Academic Press; 1995: 401426.
29. Bergmann M, Ebke M, Yuan Y, Bruck W, Mugler M, Schwendemann G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol (Berl). 1996; 92: 341350.[CrossRef][Medline] [Order article via Infotrieve]
30. Ruchoux MM, Maurage CA. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol. 1998; 24: 6065.[CrossRef][Medline] [Order article via Infotrieve]
31. Gutierrez-Molina M, Caminero RA, Martinez GC, Arpa GJ, Morales BC, Amer G. Small arterial granular degeneration in familial Binswangers syndrome. Acta Neuropathol (Berl). 1994; 87: 98105.[Medline] [Order article via Infotrieve]
32.
Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 1995; 26: 21202126.
33. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996; 16: 13731378.[CrossRef][Medline] [Order article via Infotrieve]
34. Pessin MS. Hemorrhagic transformation in the natural history of acute embolic stroke.In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolysis in Acute Ischemic Stroke. Berlin, Germany: Springer-Verlag; 1999: 6774.
35.
Dichgans M, Filippi M, Bruning R, Iannucci G, Berchtenbreiter C, Minicucci L, Uttner I, Crispin A, Ludwig H, Gasser T, Yousry TA. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999; 52: 13611367.
36.
Iannucci G, Dichgans M, Rovaris M, Brüning R, Gasser T, Giacomotti L, et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2001; 32: 643648.
37. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin: the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol. 1997; 42: 857865.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
W K Tang, Y K Chen, J Y Lu, V C T Mok, Y T Xiang, G S Ungvari, A T Ahuja, and K S Wong Microbleeds and post-stroke emotional lability J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1082 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Greenberg, R. N. K. Nandigam, P. Delgado, R. A. Betensky, J. Rosand, A. Viswanathan, M. P. Frosch, and E. E. Smith Microbleeds Versus Macrobleeds: Evidence for Distinct Entities * Supplemental Materials and Methods Stroke, July 1, 2009; 40(7): 2382 - 2386. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.N.K. Nandigam, A. Viswanathan, P. Delgado, M.E. Skehan, E.E. Smith, J. Rosand, S.M. Greenberg, and B.C. Dickerson MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Liem, S. A. J. Lesnik Oberstein, J. Haan, I. L. van der Neut, R. van den Boom, M. D. Ferrari, M. A. van Buchem, and J. van der Grond Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Progression of MR Abnormalities in Prospective 7-year Follow-up Study Radiology, December 1, 2008; 249(3): 964 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yakushiji, M. Nishiyama, S. Yakushiji, T. Hirotsu, A. Uchino, J. Nakajima, M. Eriguchi, Y. Nanri, M. Hara, E. Horikawa, et al. Brain Microbleeds and Global Cognitive Function in Adults Without Neurological Disorder Stroke, December 1, 2008; 39(12): 3323 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Sveinbjornsdottir, S Sigurdsson, T Aspelund, O Kjartansson, G Eiriksdottir, B Valtysdottir, O L Lopez, M A van Buchem, P V Jonsson, V Gudnason, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1002 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cordonnier, R. Al-Shahi Salman, and J. Wardlaw Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting Brain, August 1, 2007; 130(8): 1988 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, A. Gschwendtner, J. -P. Guichard, F. Buffon, R. Cumurciuc, M. O'Sullivan, M. Holtmannspotter, C. Pachai, M. -G. Bousser, M. Dichgans, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL Neurology, July 10, 2007; 69(2): 172 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Choi, S.-Y. Kang, J.-H. Kang, and J.-K. Park Intracerebral hemorrhages in CADASIL Neurology, December 12, 2006; 67(11): 2042 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, F. Gray, M.-G. Bousser, M. Baudrimont, and H. Chabriat Cortical Neuronal Apoptosis in CADASIL Stroke, November 1, 2006; 37(11): 2690 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Miao, T. Paloneva, S. Tuisku, S. Roine, M. Poyhonen, M. Viitanen, and H. Kalimo Arterioles of the Lenticular Nucleus in CADASIL Stroke, September 1, 2006; 37(9): 2242 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, E. J. Choi, C. G. Choi, G. Kim, J. H. Choi, H. W. Yoo, and J. S. Kim Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation Neurology, May 23, 2006; 66(10): 1511 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan and H. Chabriat Cerebral Microhemorrhage Stroke, February 1, 2006; 37(2): 550 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Koennecke Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications Neurology, January 24, 2006; 66(2): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ragoschke-Schumm, H Axer, O W Witte, S Isenmann, C Fitzek, M Dichgans, N Peters, and J Mueller-Hoecker Intracerebral haemorrhage in CADASIL J. Neurol. Neurosurg. Psychiatry, November 1, 2005; 76(11): 1606 - 1607. [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, T. G. Brott, and R. D. Brown Jr Genetics of Cerebrovascular Disorders Mayo Clin. Proc., January 1, 2005; 80(1): 122 - 132. [Abstract] [PDF] |
||||
![]() |
M Symms, H R Jager, K Schmierer, and T A Yousry A review of structural magnetic resonance neuroimaging J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1235 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van den Boom, S. A. J. Lesnik Oberstein, M. D. Ferrari, J. Haan, and M. A. van Buchem Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: MR Imaging Findings at Different Ages--3rd-6th Decades Radiology, December 1, 2003; 229(3): 683 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Wardlaw, P.A.G. Sandercock, M.S. Dennis, J. Starr, and H. Kalimo Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? Stroke, March 1, 2003; 34(3): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Messori, U. Salvolini, M. Dichgans, and M. Holtmannspotter Postmortem MRI as a Useful Tool for Investigation of Cerebral Microbleeds Stroke, February 1, 2003; 34(2): 376 - 377. [Full Text] [PDF] |
||||
![]() |
M. Dichgans A new cause of hereditary small vessel disease: Angiopathy of retina and brain Neurology, January 14, 2003; 60(1): 8 - 9. [Full Text] [PDF] |
||||
![]() |
R. von Kummer MRI: The New Gold Standard for Detecting Brain Hemorrhage? Stroke, July 1, 2002; 33(7): 1748 - 1749. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |